Cite Filings / TYRA / 0000921895-26-002613
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

Tyra Biosciences, Inc. · Filed 2026-09-21 · Acc 0000921895-26-002613

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-09-21 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-09-17 SCHEDULE 13D/A Beneficial Ownership Report
  • 2026-09-17 4 Options or other derivatives
  • 2026-09-17 4 President and CEO acquired 864 shares (grant or award)
  • 2026-09-17 4 Vice President, Finance (PAO) acquired 2,925 shares (grant or award)
  • 2026-09-17 4 Chief Financial Officer acquired 951 shares (grant or award)
  • 2026-09-17 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…